WELCOME TO OUR PARKINSON'S PLACE!

I HAVE PARKINSON'S DISEASES AND THOUGHT IT WOULD BE NICE TO HAVE A PLACE WHERE THE CONTENTS OF UPDATED NEWS IS FOUND IN ONE PLACE. THAT IS WHY I BEGAN THIS BLOG.

I COPY NEWS ARTICLES PERTAINING TO RESEARCH, NEWS AND INFORMATION FOR PARKINSON'S DISEASE, DEMENTIA, THE BRAIN, DEPRESSION AND PARKINSON'S WITH DYSTONIA. I ALSO POST ABOUT FUNDRAISING FOR PARKINSON'S DISEASE AND EVENTS. I TRY TO BE UP-TO-DATE AS POSSIBLE.

I AM NOT RESPONSIBLE FOR IT'S CONTENTS. I AM JUST A COPIER OF INFORMATION SEARCHED ON THE COMPUTER. PLEASE UNDERSTAND THE COPIES ARE JUST THAT, COPIES AND AT TIMES, I AM UNABLE TO ENLARGE THE WORDING OR KEEP IT UNIFORMED AS I WISH. IT IS IMPORTANT TO UNDERSTAND I AM A PERSON WITH PARKINSON'S DISEASE. I HAVE NO MEDICAL EDUCATION,

I JUST WANT TO SHARE WITH YOU WHAT I READ ON THE INTERNET. IT IS UP TO YOU TO DECIDE WHETHER TO READ IT AND TALK IT OVER WITH YOUR DOCTOR. I AM JUST THE COPIER OF DOCUMENTS FROM THE COMPUTER. I DO NOT HAVE PROOF OF FACT OR FICTION OF THE ARTICLE. I ALSO TRY TO PLACE A LINK AT THE BOTTOM OF EACH ARTICLE TO SHOW WHERE I RECEIVED THE INFORMATION SO THAT YOU MAY WANT TO VISIT THEIR SITE.

THIS IS FOR YOU TO READ AND TO ALWAYS KEEP AN OPEN MIND.

PLEASE DISCUSS THIS WITH YOUR DOCTOR, SHOULD YOU HAVE ANY QUESTIONS, OR CONCERNS. NEVER DO ANYTHING WITHOUT TALKING TO YOUR DOCTOR FIRST..

I DO NOT MAKE ANY MONEY FROM THIS WEBSITE. I VOLUNTEER MY TIME TO HELP ALL OF US TO BE INFORMED.

I WILL NOT ACCEPT ANY ADVERTISEMENT OR HEALING POWERS, HEALING FROM HERBS AND ETC. UNLESS IT HAS GONE THROUGH TRIALS AND APPROVED BY FDA. IT WILL GO INTO SPAM.

THIS IS A FREE SITE FOR ALL WITH NO ADVERTISEMENTS

THANK YOU FOR VISITING! TOGETHER WE CAN MAKE A DIFFERENCE!

TRANSLATE

Wednesday, July 27, 2016

Indicators of Parkinson's disease risk found in unexpected places

VAN ANDEL RESEARCH INSTITUTE
27-JUL-2016





GRAND RAPIDS, MICHIGAN,

Clues that point toward new risk mechanisms for developing Parkinson's disease are hiding in some unusual spots, according to a study published today in Scientific Reports.
Tiny changes in DNA that have been linked to Parkinson's, the second most common neurodegenerative disorder after Alzheimer's, were found not only in brain cells, where they were expected, but also in liver, fat, immune and developmental cells. These findings may one day contribute to the development of preventative interventions before the disease's effects become pronounced. 
"When we looked at the data, we were quite surprised to see the variation in tissue types," said Gerry Coetzee, Ph.D., a professor at Van Andel Research Institute (VARI) and the study's corresponding author. "Ultimately, if we can more precisely define risk factors for Parkinson's, we can develop ways to mitigate them early on. We still have a long way to go but these findings are some of the first steps down that path." 

A cumulative effect
Although these changes, called single-nucleotide polymorphisms (SNPs), are very small, an accumulation of enough SNPs can significantly heighten a person's risk for developing Parkinson's. It can be likened to dropping sand onto a scale--a single grain will have little effect, but if enough grains are added, the balance will tip. 
The human genome contains about 80 million SNPs, many of them located in regions of the DNA that were once thought to be junk. Scientists now know that these areas, located outside of genes on the DNA, play critical roles in regulating gene expression and are a useful tool for matching a particular gene with its function or role in disease. 
As such, investigating SNPs linked to Parkinson's offers a unique opportunity to answer one of the major questions in Parkinson's research--what causes or contributes to the disease? While scientists know that five to 10 percent of Parkinson's cases are passed down genetically through families, they're still determining what's behind the majority of cases. The prevailing theory is a mix of genetic and environmental factors create a perfect storm, leading to the hallmark clumping of abnormal proteins that spread through the brain, killing cells that produce a chemical called dopamine that is vital for voluntary movement. 
Intriguingly, only one locus was identified in the substantia nigra, the part of the brain where dopamine-producing neurons die. Other loci were found in liver, fat, immune and developmental cells. It is the first time this type of genome-wide analysis has been used to investigate Parkinson’s disease. NeuroscienceNews.com image is for illustrative purposes only.

Different tissues, common link
Using information from the federally funded Roadmap Epigenomics Mapping Consortium as a guide, Coetzee, the team at VARI and collaborators at Cedars-Sinai in Los Angeles analyzed 21 of these risk areas, called loci, in 77 cell types. Of these, the team found 12 loci across several tissue types that were particularly enriched--or full of SNPS--indicating an increase in risk.
Intriguingly, only one locus was identified in the substantia nigra, the part of the brain where dopamine-producing neurons die. Other loci were found in liver, fat, immune and developmental cells. It is the first time this type of genome-wide analysis has been used to investigate Parkinson's disease.
Although much more work must be done to unravel exactly how these loci affect risk, there are interesting parallels between the team's findings and recent work done by others investigating Parkinson's. For example, three of the risk loci were found in immune cells, a promising finding as evidence suggests that Parkinson's may be linked to inflammation, the immune system's reaction to help fight off potential threats.
"Only a small percentage of Parkinson's cases are familial and have a clear and well-defined genetic inheritance. The remaining cases develop the disease seemingly at random," said Patrik Brundin, M.D., Ph.D., director of VARI's Center for Neurodegenerative Science and one of the study's authors. "The emerging view is that Parkinson's is more of a syndrome--a defined set of clinical symptoms and some shared features of brain pathology--with a diverse set of underlying causes. One surprising finding in our study is that only one gene locus was clearly linked to the brain while others were associated with tissues throughout the body. This supports the emerging theory that Parkinson's is a disorder that can be caused by disruptions in cellular processes in many locations, not just one. Furthermore, for the disease to develop in one person there has to be an unfortunate combination of a genetic predisposition and, as yet undefined, environmental insults." 
###
This work was supported by funding from Van Andel Research Institute and Cedars-Sinai.

What is Parkinson's?
Parkinson's disease is a progressive neurological disease marked by tremor, rigidity and loss of voluntary movement, among other non-motor symptoms. Between seven and 10 million people globally have the disease. Of those, the majority of cases have no known cause although scientist suspect a mix of genetic, epigenetic and environmental factors.

What is a SNP?
DNA is like a ladder, with the rungs being pairs of molecules called nucleotides. Single-nucleotide polymorphisms, or SNPs, are variations in one of these nucleotides at a specific point on DNA. Although SNPs are extremely useful tools in finding genes linked to diseases, it can be very difficult to make these connections as SNPs can be located far away on the genome from the gene they affect.

What are genome-wide association studies?
Genome-wide association studies (GWAS) compare the genomes of a healthy control group to a test group, for example people with Parkinson's, to see where there are differences in their genetic makeup.

ABOUT VAN ANDEL RESEARCH INSTITUTE
Van Andel Institute (VAI) is an independent nonprofit biomedical research and science education organization committed to improving the health and enhancing the lives of current and future generations. Established by Jay and Betty Van Andel in 1996 in Grand Rapids, Michigan, VAI has grown into a premier research and educational institution that supports the work of more than 360 scientists, educators and staff. Van Andel Research Institute (VARI), VAI's research division, is dedicated to determining the epigenetic, genetic, molecular and cellular origins of cancer, Parkinson's and other diseases and translating those findings into effective therapies. The Institute's scientists work in onsite laboratories and participate in collaborative partnerships that span the globe. 100% To Research, Discovery & Hope® http://www.vai.org
Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.


http://www.eurekalert.org/pub_releases/2016-07/vari-iop072716.php?

No comments:

Post a Comment